FTC's Brill backs proposal to outlaw 'pay-for-delay' drug settlements
The US Federal Trade Commission’s senior Democrat said she would support proposed legislation that would prohibit agreements between branded drug companies and generic rivals that are aimed at keeping cheaper medicines...To view the full article, register now.
Already a subscriber? Click here to view full article